IP Library Granted Patent US 10,501,503
Granted Patent B2
US 10,501,503 · App. 15/774,820 · Granted Dec 10, 2019

Modified membrane permeability

Inventors: Howard Chou (Shanghai, CN); Lijun Yu (Shanghai, CN); Xiucai Liu (Shanghai, CN)
Assignees: Cathay Biotech Inc.; CIBT America Inc.
C07K14/245C12N9/88C12N15/70C12P13/001C12P13/08C12Y401/01018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,503
App. No.
15/774,820
Granted
Dec 10, 2019
Kind
B2
Abstract

Provided are microorganisms genetically modified to overexpress porin polypeptides to enhance the production of lysine and lysine derivatives by the microorganism. Also provided are methods of generating such microorganism, and methods of producing lysine and lysine derivatives using the genetically modified microorganisms.

Claims (11)

1. A genetically modified host cell comprising a heterologous nucleic acid encoding an OMP porin polypeptide, wherein the host cell overexpresses the OMP porin polypeptide and has increased production of an amino acid lysine and cadaverine, and wherein the OMP porin polypeptide is an OmpA, OmpC, OmpF, OmpX, OmpE, OmpG, or OmpW porin polypeptide set forth as SEQ ID NO: 4, 6, 8, 10, 12, 14, or 16 respectively; or wherein the OMP porin polypeptide is a conservatively modified porin polypeptide variant of SEQ ID NO: 4, 6, 8, 10, 12, 14, or 16 that encodes the mature OMP porin polypeptide.

2. The genetically modified host cell of claim 1 , wherein the heterologous nucleic acid encoding the OMP porin polypeptide is encoded by an expression vector introduced into the cell, wherein the expression vector comprises the heterologous nucleic acid operably linked to a promoter; and/or

wherein the OMP porin polypeptide is endogenous to the host cell; and/or

wherein the heterologous nucleic acid is integrated into the host chromosome; and/or

wherein the host cell overexpresses a lysine decarboxylase; and/or

wherein the host cell overexpresses one or more lysine biosynthesis polypeptides; and/or

wherein the host cell overexpresses a TetA polypeptide.

3. The genetically modified host cell of claim 1 , wherein the host cell is of the genus Escherichia, Hafnia , or Corynebacterium ; and/or wherein the host cell is Escherichia coli, Hafnia alvei , or Corynebacterium glutamicum ; and/or wherein the host cell is Escherichia coli or Hafnia alvei.

4. The genetically modified host cell of claim 3 , wherein the Omp porin polypeptide is an OmpA, OmpC, OmpF, or OmpW polypeptide.

5. The genetically modified host cell of claim 4 , wherein the host cell overexpresses a lysine decarboxylase polypeptide; and/or wherein the host cell overexpresses a LysC, DapA, LysA, Asd, DapB, AspC, or TetA polypeptide.

6. A method of producing an amino acid, the method comprising culturing a host cell of claim 1 under conditions in which the OMP porin polypeptide is overexpressed.

Assignments (3)
CHANGE OF NAME Recorded Sep 17, 2019
From: SHANGHAI CATHAY BIOTECH R&D CENTER LTD.
To: CATHAY BIOTECH INC.
Reel/Frame 050397/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2019
From: CATHAY INDUSTRIAL BIOTECH LTD.
To: CIBT AMERICA INC.
Reel/Frame 050360/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2018
From: CHOU, HOWARD; YU, LIJUN; LIU, XIUCAI
To: CATHAY R&D CENTER CO., LTD.; CATHAY INDUSTRIAL BIOTECH LTD.
Reel/Frame 045754/0923 →
Continuity (1)
Related Publication 20190031726A1 · Jan 31, 2019